ClinicalTrials.Veeva

Menu

Hearing Health Equity Through Accessible Research and Solutions for Korean Americans (K-HEARS)

Johns Hopkins University logo

Johns Hopkins University

Status

Invitation-only

Conditions

Community-dwelling Seniors
Age-related Hearing Impairment
Korean
Hearing Loss
Hearing Impairment
Personal Communication

Treatments

Behavioral: K-HEARS Intervention
Device: K-HEARS Sound Amplifier Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06803394
R01DC019686 (U.S. NIH Grant/Contract)
IRB00406742

Details and patient eligibility

About

The objective of this study is to test the effect of a community-delivered, affordable, and accessible hearing care intervention on improving communication function and health-related quality of life among older Korean Americans (KA) and the older Korean American's care partners that integrates a low-cost over-the-counter amplification device and hearing rehabilitation in comparison to a 6-month delayed treatment group through a cluster randomized controlled study.

Enrollment

800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

PARTICIPANT CRITERIA Participant inclusion criteria

  • Self-identified as first-generation KA in the target region
  • Age 60 years or older
  • Has a communication partner who lives in the same household or has at least weekly interactions
  • Screening audiometry Pure-tone audiometry (PTA)1,2,4 kilohertz (kHz) >25 decibel (dB) hearing loss (HL) in better ear
  • Hearing handicap as measured by HHIE-S score >=8 Participant exclusion criteria
  • Current use of hearing aid
  • Medical contraindications to use amplification device (e.g., draining ear)
  • Plan to move from the area within 6 months
  • Active treatment for a terminal illness or in hospice

COMMUNICATION PARTNER CRITERIA Communication Partner inclusion criteria

  • Age 18 years or older
  • Able to read and speak Korean
  • Lives with the older adult or has at least weekly interactions Communication Partner exclusion criteria
  • Plan to move from the area within 6 months
  • Active treatment for a terminal illness or in hospice

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

800 participants in 2 patient groups, including a placebo group

Immediate Treatment Site
Experimental group
Description:
Study site assigned to immediate treatment of K-HEARS intervention
Treatment:
Device: K-HEARS Sound Amplifier Intervention
Behavioral: K-HEARS Intervention
Delayed Treatment Site
Placebo Comparator group
Description:
Study site assigned to 6-month delayed treatment of K-HEARS intervention
Treatment:
Device: K-HEARS Sound Amplifier Intervention
Behavioral: K-HEARS Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Hae-Ra Han, PhD, RN; Carrie L Nieman, MD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems